Amgen Boosts Outlook as Profit Rises 50%

Amgen Inc. raised its 2015 guidance as the biotechnology company reported that its third-quarter earnings rose 50% on stronger revenue led by Enbrel and other key drugs.

U.S. Drugmaker Turing to Roll Back 5,000% Price Hike

Turing Pharmaceuticals, a small company that generated outrage over raising the cost of an old anti-infective drug by more than 5,000%, said on Tuesday it would roll back that increase to make sure it remains affordable.